Sign in
4/A

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001209191-22-036715

Chief Scientific Officer gave up 1,102 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fisher Stewart Chief Scientific Officer 2022-05-26 Shares withheld for taxes −1,102 $7.01 $7,725 74,038 D
Loading xslF345X03/doc4a.xml…